US Stock MarketDetailed Quotes

GEV GE Vernova

Watchlist
  • 420.490
  • -17.220-3.93%
Close Jan 24 16:00 ET
  • 420.503
  • +0.013+0.00%
Post 20:01 ET
116.00BMarket Cap74.74P/E (TTM)

GE Vernova Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GE Vernova Q4 2024 Earnings Date

Currency：USDJan 22, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
10.70B
10.56B
-140.07M
Miss Est.
--
+5.12%
-1.31%
EPS
2.44
1.73
-0.71
Miss Est.
--
+399.12%
-29.17%
Analyst Rating
Strong Buy

Jan 24, 2025

GE Vernova Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 8.700B--
--2025/Q1-- / 7.593B--
Jan 22, 20252024/Q410.559B / 10.699B--
Oct 23, 20242024/Q38.913B / 8.760B--
--2024/Q28.204B / 8.259B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 8.700B--
--2025/Q1-- / 7.593B--
Jan 22, 20252024/Q410.559B / 10.699B--
Oct 23, 20242024/Q38.913B / 8.760B--
--2024/Q28.204B / 8.259B--

Unlock Free Earnings Estimates

GE Vernova Earnings Reports

  • GE Vernova | 8-K: GE Vernova reports fourth quarter and full year 2024 financial results

    Jan 22 06:26 ET

  • GE Vernova | 10-Q: Quarterly report

    Oct 23, 2024 06:41 ET

  • GE Vernova | 8-K: GE Vernova Reports Third Quarter 2024 Financial Results Solid 3Q'24 results with double-digit orders and continued revenue growth, along with substantial cash flow

    Oct 23, 2024 06:25 ET

  • GE Vernova LLC | 10-Q: Quarterly report

    Jul 24, 2024 06:42 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Collegium Pharmaceutical
    COLL
    +2.36%
    Constellation Brands
    STZ
    +2.01%
    Ermenegildo Zegna NV
    ZGN
    +1.57%
    DexCom
    DXCM
    +1.20%
    Workday
    WDAY
    +1.17%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 24, 2025

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data